Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1991-06-25
1992-08-25
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
5142275, 5142375, 514255, 514325, 514423, 514616, 514617, 514618, 514620, 544 584, 544154, 544155, 544380, 546195, 548528, 564153, 564154, 564156, 564162, 564163, 564166, 564167, 564168, A61K 31165, C07C23714
Patent
active
051419602
ABSTRACT:
A class of tricyclic glycinamide derivatives is described having use in treatment of CNS dysfunctions such as epilepsy and convulsive disorders. Compounds of most interest are those of the formula ##STR1## wherein each of X and Y is hydrido; wherein Z is selected from methylene, ethylene, ethenylene, thiomethylene and thioethylene; and wherein each of R.sup.1, R.sup.2 and R.sup.3 is hydrido; or a pharmaceutically-acceptable salt thereof.
REFERENCES:
patent: 3821249 (1974-06-01), Malen et al.
patent: 4025651 (1977-05-01), Kirino et al.
patent: 4267344 (1981-05-01), Halstrom et al.
patent: 4639468 (1987-01-01), Roncucci et al.
R. M. Peck et al, J. Med. Chem., 19(12), 1422-1423 (1976).
B. Wysocka-Skrzela, Pol. J. Chem., 56(10-12), 1573-1576 (1982).
J. Pless, Helv. Chim. Acta., 59, Fasc. 2, Nr. 53, 499-512 (1976).
B. Gaugain, Biochem., 20, 3035-3042 (1981).
V. A. Shibnev et al, Bioorg. Khim., 10(7), 921-926 (1984).
Cordi Alexis A.
Gillet Claude L.
G. D. Searle & Co.
Keane J. Timothy
Matukaitis Paul D.
Raymond Richard L.
Smith Charles E.
LandOfFree
Tricyclic glycinamide derivatives as anti-convulsants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic glycinamide derivatives as anti-convulsants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic glycinamide derivatives as anti-convulsants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-385390